![Paul Tulcinsky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Tulcinsky
Keine laufenden Positionen mehr
Karriereverlauf von Paul Tulcinsky
Ehemalige bekannte Positionen von Paul Tulcinsky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OncoRadiomics SA
![]() OncoRadiomics SA Investment Trusts/Mutual FundsMiscellaneous OncoRadiomics SA functions as a foundation or endowment. Its products include radiomix, distrim and virtual patient auatar. The company was founded by Ralph Leijenaar, Sean Walsh and Tulcinsky Paul on September 19, 2016 and is headquartered in Liège, Belgium. | Gründer | 19.09.2016 | - |
Convert Pharmaceuticals SA
![]() Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Gründer | 24.02.2017 | - |
Statistik
International
Belgien | 3 |
Operativ
Founder | 2 |
Sektoral
Commercial Services | 2 |
Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Convert Pharmaceuticals SA
![]() Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Commercial Services |
OncoRadiomics SA
![]() OncoRadiomics SA Investment Trusts/Mutual FundsMiscellaneous OncoRadiomics SA functions as a foundation or endowment. Its products include radiomix, distrim and virtual patient auatar. The company was founded by Ralph Leijenaar, Sean Walsh and Tulcinsky Paul on September 19, 2016 and is headquartered in Liège, Belgium. | Miscellaneous |
- Börse
- Insiders
- Paul Tulcinsky
- Erfahrung